Pharmaceutical sales in China.
Sinopharm and Pfizer signed a Chinese sales agency agreement for Parovide oral medicine, and Sinopharm became the general agent of Parovide’s original drug in China.
Parovide is a product of Pfizer Inc., which was founded in 1849 and has a history of more than 170 years. It is headquartered in New York, USA. It is a science-based, An innovative, patient-first biopharmaceutical company. Pfizer's goal is to "bring breakthrough innovations to patients that change their lives." Pfizer entered the Chinese market in 1989.